Soumyajit Roy

21PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyHaematologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 28, 2026
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

|Sep 26, 2026
External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

|Aug 12, 2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

|Jan 13, 2026
Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada.

David-Dan Nguyen, Raj Satkunasivam, Khatereh Aminoltejari

|Dec 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

|Dec 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

Pageof 4

Frequent Collaborators

10 joint publications

Daniel Spratt

10 joint publications

Cristopher J D Wallis

9 joint publications

Scott Morgan

6 joint publications

Shawn Malone